A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was whether bronchoscopic or other minimal access approaches to the closure of bronchopleural fistulae (BPFs) were effective compared to a conventional re-thoracotomy. Our search identified 1052 abstracts, from which we identified six case series of greater than two postpneumonectomy bronchopleural fistula patients. These series included reports of bronchial stenting, glue occlusion and scar obliteration of fistulae. No thoracoscopic techniques were reported except in case report form. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of these papers are tabulated. We identified 85 postpneumonectomy bronchopleural fistulae reported in the literature who underwent bronchoscopic procedures to attempt repair. There was a 30% cure rate using a range of bronchoscopic techniques in these series. Bronchoscopic techniques included cyanoacrylate or fibrin glue application, YAG laser therapy, injection of the vein sclerosant polidocanol and tracheo-bronchial stenting. The mortality was 40% in these patients reflecting the very high mortality with this complication. Many patients required multiple bronchoscopic procedures and also further drainage procedures of their empyemas. Bronchoscopic treatment has so far only been reported in small case series but may offer further treatment options in patients too unwell to undergo re-thoracotomy.
Introduction
A best evidence topic was constructed according to a structured protocol. The protocol is fully described in the ICVTS w1x.
Clinical scenario
You perform a right pneumonectomy for a cT2 cN1 cM0 non-small-cell lung cancer, in a 77-year-old diabetic with a history of ischaemic heart disease.
On the sixth postoperative day he deteriorates, with a copious productive cough, worsening gas exchange, pyrexia and rising inflammatory markers. Chest X-ray shows a fall in fluid level, and fibreoptic bronchoscopy confirms a bronchopleural fistula (BPF), with dehiscence of one third of your staple line. The intercostal drain you site recovers 700 ml of purulent fluid. You feel that he would not survive a repeat thoracotomy and wonder if a bronchoscopic approach might work? *Corresponding author. Tel.: q44 141 211 2624; fax: q44 141 211 1751. E-mail address: dgwest@rcsed.ac.uk (D. West).
Three-part question
In wpatients with a bronchopleural fistulax is a wminimal access or bronchoscopic approach superior to conventional re-thoracotomyx for BPF closure in terms of wsurvivalx.
Search strategy
Medline 1950 -2007 database, and EMBASE database 1980 -2007 the Ovid interface.
wexp Bronchial fistulayOR bronchopleural fistula.mp OR bronchial dehiscence.mp OR exp respiratory tract fistulayx AND wexp thoracoscopyyOR thoracoscopy.mp OR exp thoracic surgery, video-assistedyOR exp surgical procedures, minimally invasiveyOR minimally invasive.mp OR minimal access.mpx AND woutcome.mp OR outcome$.mp OR exp intraoperative complicationsyOR exp empyema OR empyema.mp OR complication$.mp OR exp treatment outcomeyx. The Cochrane Register of Systematic Reviews was also searched for relevant studies. Results were restricted to studies on human subjects published in the English language.
Search outcome
The search identified 1052 abstracts in Medline and Embase. Abstracts were hand-searched, and several identified Downloaded from https://academic.oup.com/icvts/article-abstract/6/4/547/746782 by guest on 28 December 2018 for full manuscript assessment. No randomised trials, two narrative review articles, several case series and many case reports were identified for manuscript review. Reports of two patients or less were excluded from further study. Reports containing both post-lobectomy and post-pneumonectomy were assessed on their post-pneumonectomy content alone. The papers finally considered to be the best evidence are summarised in Table 1.
Discussion
Bronchopleural fistula is a disastrous complication following pneumonectomy, with high morbidity. Incidence after pneumonectomy in a recent series was 12%, and mortality with fistula was 67% w8x. Impaired respiratory mechanics, contralateral lung contamination and chronic pleural sepsis all contribute to its poor outcome. Conventional surgical strategies such as thoracoplasty or chest wall fenestration carry significant mortality in themselves, and long-term morbidity with pain and deformity. Reducing the morbidity of therapy with a minimal access approach is, therefore, appealing. The fistula site is accessible by bronchoscopy and/or thoracoscopy, which may avoid major surgery in these high-risk patients may reduce risk.
Our search strategy produced reports of several different procedures. They can be broadly categorised as (1) tracheobronchial stenting, (2) occlusion with glue or other materials, and (3) procedures to induce scar tissue formation at the fistula. We decided to exclude from our table series of two cases or less. Case reports of other treatments, including thoracoscopic closure, were excluded on these grounds. The search also identified two recent topic reviews w9, 10x.
Endobronchial stenting has been used to isolate fistulas in several case reports, but our search identified only one series of more than two patients w4x. The authors used specially-designed covered metal stents (with a blindending arm to fit the bronchial stump) in six patients. The mortality rate at a mean follow-up of 316 days was 0%, with 67% of patients cured of both fistula and empyema. Patients in this series underwent follow-up CT scan and bronchoscopy to confirm adequate stent placement. This initial study is encouraging, although it is not populationbased, making the effect of case-selection hard to quantify. It does, however, establish the feasibility of the technique in selected patients.
Fibrin glue occlusion was used in a large series of 45 postresection fistulas (40 post-pneumonectomy) -8 mm in diameter w2x. Only 20% of cases were cured with this technique, with resolution of both fistula and empyema. However, the majority had an adverse outcome, with 20% dying as in-patients, 35.6% progressing to surgery and 15.6% left with a chronic empyema. Another series using synthetic glue in 12 post-pneumonectomy fistulas had a better fistula resolution rate (66.7%) and survival of 83%, but disappointingly only 10% of empyemas resolved w5x. The authors' impression was that small and late-presentation fistulas responded better to glue, although the numbers were too small for statistical analysis. Sabanathan w7x also used cyanoacrylate glue in three patients, with no mortality, but resolution of BPF and empyema was only achieved in one patient (33%). The other two required open omentopexy.
Lastly, reported scar-forming techniques have included the Nd:YAG laser w6x and sub-mucosal injection of the vein sclerosant polidocanol w3x. Resolution of BPF ranged from 33% to 58%, and mortality from 26% to 66%. Both of these techniques involved repeated bronchoscopic interventions in most patients. Other techniques included bronchoscopic submucosal alcohol injection w11x and thoracoscopic gluing or clipping w12x.
The pooled mortality in amongst 90 patients reported in these five series (including five BPFs following lobectomy) is 39.6%. Of 85 post-pneumonectomy BPFs reported in these series, 30.1% were cured of both BPF and associated empyema (when present) by bronchoscopic treatment alone.
These outcomes could clearly still be improved. Fistula size, time of onset from surgery, bronchial stump length and aetiology of stump failure (e.g. tumour recurrence) vary. It may be that some strategies are useful for specific types of BPF. For example, several authors have suggested that glue and scarring techniques seem better suited to smaller fistulas w2, 3, 5x. Concentrating on fistula subsets with specific techniques may improve results.
Clinical bottom line
In 85 post-pneumonectomy BPFs there was a 30% cure rate using a range of bronchoscopic techniques. The mortality was approximately 40% reflecting the very high mortality with this complication. Bronchoscopic treatment has so far only been reported in small case series but may in the future offer further treatment options in patients too unwell to undergo re-thoracotomy.
